NO920591L - Substituerte benzofuranylpiperidiner som nootropikum - Google Patents
Substituerte benzofuranylpiperidiner som nootropikumInfo
- Publication number
- NO920591L NO920591L NO92920591A NO920591A NO920591L NO 920591 L NO920591 L NO 920591L NO 92920591 A NO92920591 A NO 92920591A NO 920591 A NO920591 A NO 920591A NO 920591 L NO920591 L NO 920591L
- Authority
- NO
- Norway
- Prior art keywords
- nootropicum
- piperidines
- substituted benzofuranyl
- treatment
- disorders
- Prior art date
Links
- -1 BENZOFURANYL PIPERIDINES Chemical class 0.000 title 1
- 230000001777 nootropic effect Effects 0.000 abstract 2
- 208000012902 Nervous system disease Diseases 0.000 abstract 1
- 208000025966 Neurological disease Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- WZXHSWVDAYOFPE-UHFFFAOYSA-N brofaromine Chemical compound C=1C2=CC(OC)=CC(Br)=C2OC=1C1CCNCC1 WZXHSWVDAYOFPE-UHFFFAOYSA-N 0.000 abstract 1
- 230000007850 degeneration Effects 0.000 abstract 1
- 230000003412 degenerative effect Effects 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 210000002569 neuron Anatomy 0.000 abstract 1
- 239000002664 nootropic agent Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH47091 | 1991-02-15 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO920591D0 NO920591D0 (no) | 1992-02-14 |
| NO920591L true NO920591L (no) | 1992-08-17 |
| NO179358B NO179358B (no) | 1996-06-17 |
| NO179358C NO179358C (no) | 1996-09-25 |
Family
ID=4187740
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO920591A NO179358C (no) | 1991-02-15 | 1992-02-14 | Anvendelse av substituerte benzofuranylpiperidiner som nootropikum |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0499586B1 (no) |
| JP (1) | JPH0570352A (no) |
| KR (1) | KR920016098A (no) |
| AT (1) | ATE138805T1 (no) |
| AU (1) | AU655227B2 (no) |
| CA (1) | CA2061015A1 (no) |
| DE (1) | DE59206442D1 (no) |
| DK (1) | DK0499586T3 (no) |
| ES (1) | ES2087497T3 (no) |
| GR (1) | GR3020155T3 (no) |
| IE (1) | IE74906B1 (no) |
| IL (1) | IL100889A (no) |
| MX (1) | MX9200620A (no) |
| NO (1) | NO179358C (no) |
| NZ (1) | NZ241608A (no) |
| ZA (1) | ZA921091B (no) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU3595093A (en) * | 1992-02-21 | 1993-09-13 | Ciba-Geigy Ag | Brofaromine as an agent for treating social phobia |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE175358T1 (de) * | 1987-10-22 | 1999-01-15 | Massachusetts Inst Technology | Behandlung des prämenstruellen oder späten lutealsphase-syndroms |
-
1992
- 1992-02-06 ES ES92810085T patent/ES2087497T3/es not_active Expired - Lifetime
- 1992-02-06 DK DK92810085.8T patent/DK0499586T3/da active
- 1992-02-06 EP EP92810085A patent/EP0499586B1/de not_active Expired - Lifetime
- 1992-02-06 DE DE59206442T patent/DE59206442D1/de not_active Expired - Fee Related
- 1992-02-06 AT AT92810085T patent/ATE138805T1/de not_active IP Right Cessation
- 1992-02-06 IL IL100889A patent/IL100889A/xx not_active IP Right Cessation
- 1992-02-10 AU AU10877/92A patent/AU655227B2/en not_active Ceased
- 1992-02-13 NZ NZ241608A patent/NZ241608A/en unknown
- 1992-02-13 MX MX9200620A patent/MX9200620A/es not_active IP Right Cessation
- 1992-02-13 CA CA002061015A patent/CA2061015A1/en not_active Abandoned
- 1992-02-13 KR KR1019920002074A patent/KR920016098A/ko not_active Abandoned
- 1992-02-14 JP JP4028252A patent/JPH0570352A/ja active Pending
- 1992-02-14 IE IE920486A patent/IE74906B1/en not_active IP Right Cessation
- 1992-02-14 NO NO920591A patent/NO179358C/no unknown
- 1992-02-14 ZA ZA921091A patent/ZA921091B/xx unknown
-
1996
- 1996-06-06 GR GR960401246T patent/GR3020155T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK0499586T3 (da) | 1996-06-24 |
| AU655227B2 (en) | 1994-12-08 |
| GR3020155T3 (en) | 1996-09-30 |
| JPH0570352A (ja) | 1993-03-23 |
| ATE138805T1 (de) | 1996-06-15 |
| AU1087792A (en) | 1992-08-20 |
| MX9200620A (es) | 1992-08-01 |
| NO179358B (no) | 1996-06-17 |
| NO920591D0 (no) | 1992-02-14 |
| EP0499586B1 (de) | 1996-06-05 |
| NO179358C (no) | 1996-09-25 |
| ES2087497T3 (es) | 1996-07-16 |
| IL100889A (en) | 1997-03-18 |
| IE74906B1 (en) | 1997-08-13 |
| IE920486A1 (en) | 1992-08-26 |
| NZ241608A (en) | 1997-06-24 |
| ZA921091B (en) | 1992-09-30 |
| EP0499586A1 (de) | 1992-08-19 |
| DE59206442D1 (de) | 1996-07-11 |
| KR920016098A (ko) | 1992-09-24 |
| CA2061015A1 (en) | 1992-08-16 |
| IL100889A0 (en) | 1992-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO931056L (no) | Sulfonamido- og sulfonamidokarbonyl-pyridin-2-karboksylsyreamider samt deres pyridin-n-oksider, fremgangsmaater for fremstilling derav og anvendelse av forbindelsene som legemidler | |
| ES2139638T3 (es) | 1,4-piperazinas disustituidas para el tratamiento de las enfermedades del sistema nervioso central y de las enfermedades neuroendocrinas. | |
| NO961687L (no) | Nye (R)-5-karbamoyl-8-fluor-3-N,N-disubstituerte-amino-3,4-dihydro-2H-1-benzopyraner | |
| NO921609D0 (no) | Sulfonamider og deres medisinske anvendelse | |
| NL300006I1 (nl) | Imidazolylalkeenzuurderivaten. | |
| DK0734383T3 (da) | Cykliske amidderivater som neurokinin-A-antagonister | |
| EP0354777A3 (en) | 3-(4-piperidine)-5-(2-sulfonylaminoethyl) indole derivatives | |
| DE69216293D1 (de) | 1,4-Disubstituierte Piperidinderivate, ihre Herstellung und therapeutische Verwendung | |
| NO941884D0 (no) | 1,3-substituerte cykloalkener og cykloalkaner som sentralnervesystem-midler | |
| HUT56077A (en) | Process for producing n-(imidazolyl-alkyl)-alanyl derivatives with substituents and pharmaceutical compositions containing them as active components | |
| NO980923L (no) | Optisk aktivt fenylpyrimidin-derivat som analgetisk middel | |
| NO952624L (no) | Antihyperglykemisk aktivt legemiddel | |
| NO920591D0 (no) | Substituerte benzofuranylpiperidiner som nootropikum | |
| PT92671A (pt) | Processo para a preparacao de ariloxipropanolaminotetralinas farmaceuticamente activas | |
| NO166788C (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydrobenzofuro(2,3-c)-pyridiner. | |
| SE8603517D0 (sv) | Heterocyclic compounds and their preparation and pharmaceutical formulation | |
| ZW6889A1 (en) | &-adrenergic receptor antagonists | |
| DK286090A (da) | Alfa-adrenerge receptorantagonister | |
| DK0573360T3 (da) | Pyrrolothienopyrazinforbindelser som 5-HT3-receptorantagonister |